{"id":"W2565823447","doi":"10.1182/blood.v112.11.2401.2401","title":"Cost-Effectiveness of Adding Imatinib to Chemotherapy in Adult Patients with Chromosom-Positive Acute Lymphoblastic Leukemia (Ph+ALL): A Canadian Perspective","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Imatinib; Medicine; Internal medicine; Imatinib mesylate; Oncology; Disease; Chemotherapy; Intensive care medicine; Myeloid leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001624991,0.0007045802,0.0008647973,0.001073122,0.001080631,0.002085684,0.001456403,0.001267746,0.004949826],"category_scores_gemma":[0.007891783,0.0004331888,0.001893408,0.001732658,0.0007400855,0.0007030359,0.0008361449,0.001395435,0.000156841],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.05470024,"about_ca_system_score_gemma":0.03659637,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9036575,"about_ca_topic_score_gemma":0.8882936,"domain_scores_codex":[0.9986503,0.0004755543,0.00004850804,0.000111407,0.0002493141,0.0004651115],"domain_scores_gemma":[0.9977745,0.001031414,0.0002932751,0.0000408108,0.0004383585,0.0004216255],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","study_design_scores_codex":[0.005147337,0.0003822347,0.0713302,0.0006115496,0.001350627,0.0009171049,0.0002883481,0.8517018,0.0009994252,0.02537857,0.008692454,0.03320028],"study_design_scores_gemma":[0.002328503,0.002057341,0.09287242,0.0005735729,0.002823419,0.000881066,0.001682773,0.8717486,0.0008147995,0.01111144,0.0128456,0.0002604668],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9357081,0.007253741,0.002718382,0.01136685,0.0001126203,0.0004697008,0.01045159,0.00004699541,0.03187195],"genre_scores_gemma":[0.9953914,0.001611257,0.0009661662,0.0002851143,0.00001599965,0.00003218718,0.000917481,0.000005978667,0.0007745003],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0963425,"threshold_uncertainty_score":0.3968799,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01286055778712614,"score_gpt":0.2742051226941706,"score_spread":0.2613445649070444,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}